India’s pharma market grew by 8.4% during the financial year 2024-25, propelled by strong performance in key chronic therapy areas, according to market research firm Pharmarack.
The cardiac segment led with a 10.8% value growth, followed closely by gastrointestinal (10.2%) and anti-diabetic (8%) therapies.
Together, these three therapy areas contributed 34% of the total pharma market sales, helping push the industry’s overall turnover to over ₹2.25 trillion.
Despite the chronic therapies dominating in growth, GSK’s antibiotic Augmentin emerged as the top-selling drug of FY25 with ₹816 crore in sales.
USV’s Glycomet GP, an anti-diabetic medication, followed closely with ₹803 crore in sales.
While value growth was strong, unit sales in the domestic market recorded a modest 1.2% increase, indicating that growth was largely price-driven.
March 2025 saw a significant market shift with the diabetes molecule empagliflozin going off-patent.
Within a month, 86 brands from 19 companies launched empagliflozin-based products. Sheetal Sapale, vice-president (commercial) at Pharmarack, noted a steep price drop—around 85%—with prices falling from ₹60-70 per tablet to just ₹5-15.
Despite a rise in volume, the value declined due to this price erosion.
The launch of Eli Lilly’s Mounjaro (tirzepatide) in March 2025 added momentum to India’s emerging anti-obesity market.
In just one month, Mounjaro contributed ₹1.4 crore to the segment’s ₹576 crore moving annual turnover. Semaglutide, another GLP-1-based drug, accounted for 69% of this total over the previous 12 months.
Several leading pharma companies posted strong domestic value growth in March 2025. Sun Pharma (14.9%), Torrent Pharma (14.7%), Intas (12.8%), and Zydus (10.8%) all recorded double-digit growth.
Overall, the pharma market witnessed a 7.5% value growth and 1.8% unit growth in March alone, reflecting broad-based strength across segments.
Also Read: India’s $2.7 Billion PLI Scheme Set To Boost Local Electronics Manufacturing
On Friday, the FBI and ERO apprehended Harpreet Singh, a terrorist involved in multiple attacks…
A new book, 'Sanskriti Ka Paanchva Adhyay', compiling PM Modi’s speeches on Indian culture, will…
Leaders across India paid tribute to Guru Tegh Bahadur on his birth anniversary, honoring his…
On Good Friday, PM Modi paid tribute to the sacrifice of Jesus Christ, encouraging people…
NQXT is a highly efficient and cash-generating asset that will consolidate APSEZ’s presence along the…
Smita Kabra began channeling her creativity into action, starting with small-scale initiatives like organizing summer…